M

Researcher Profile

Michael J. Yellin

3

Publications

13,090

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article Journal of Clinical Oncology Jun 20, 2017

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

Howard A. Burris · Jeffrey R. Infante · Stephen M. Ansell · John J. Nemunaitis +11 more

10.1200/jco.2016.70.1508 124 citations

Journal Article Journal of Clinical Oncology May 10, 2015

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

Denise A. Yardley · Robert Weaver · Michelle E. Melisko · Mansoor N. Saleh +16 more

10.1200/jco.2014.56.2959 162 citations

Journal Article New England Journal of Medicine Aug 19, 2010

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi · Steven J. O'Day · David F. McDermott · Robert W. Weber +25 more

10.1056/nejmoa1003466 12,804 citations

Publication Timeline

2017

1

2015

1

2010

1

Frequent Co-Authors

Thomas A. Davis

Elizabeth Crowley

Linda T. Vahdat

Geoffrey M. Nichol

Jessica C. Hassel

Thomas Hawthorne

Branimir I. Sikic